Showing results (21-30 of 113) with videos related to
Sort By:
Pageof 12
Schweizerische Medizinische Wochenschrift|August 23, 2000
Applying some UK Prospective Diabetes Study results to Switzerland: the cost-effectiveness of intensive glycaemic control with metformin versus conventional control in overweight patients with type-2 diabetesA J Palmer, P P Sendi, G A SpinasInternational Journal of Clinical Practice|September 20, 2007
Irbesartan treatment of patients with type 2 diabetes, hypertension and renal disease: a UK health economics analysisA J Palmer, W J Valentine, J A RayHaemostasis|March 1, 1997
Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: a meta-analysis of randomised clinical trialsA J Palmer, W Schramm, B Kirchhof, et al.Journal of Clinical Pharmacy and Therapeutics|June 1, 1988
Qualitative studies on alpha-interferon-2b in prolonged continuous infusion regimes using gradient elution high-performance liquid chromatographyA J Palmer, G J Sewell, C G RowlandOsteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 29, 2011
Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention studyM S Cooper, A J Palmer, M J SeibelPraxis|March 31, 2006
[Health economic consequences of the use of irbesartan in patients with type 2 diabetes, hypertension and nephropathy in Switzerland]A Frei, A J Palmer, M Burnier, et al.Pharmacoeconomics|September 11, 2001
Highly active antiretroviral therapy: pharmacoeconomic issues in the management of HIV infectionP Sendi, A J Palmer, A Gafni, et al.Journal of Human Hypertension|June 1, 1996
The prevalence of pseudohypertension in the elderlyM Anzal, A J Palmer, J Starr, et al.Swiss Medical Weekly|October 5, 2001
Economic and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss settingV Gozzoli, A J Palmer, A Brandt, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 9, 2015
Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness modelL Si, T M Winzenberg, Q Jiang, et al.Pageof 12